Biotech is a biotechnology company that develops cancer therapies.
BiVictriX Therapeutics has raised $473K in total funding. The most recent round was Grant. The last funding was announced in June 2024.
BiVictriX Therapeutics's investors include Development Bank of Wales, Innovate UK, O2h Ventures, Alderley Park Ventures.
BiVictriX Therapeutics is headquartered in Alderley Edge, United Kingdom.
Biotech is a biotechnology company that develops cancer therapies.
BiVictriX Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BiVictriX Therapeutics — Funding & Investors." VCBacked, June 6, 2024, https://www.vcbacked.co/company/bivictrix-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). BiVictriX Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/bivictrix-therapeutics
{{cite web |title=BiVictriX Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bivictrix-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated